Papillary Thyroid Carcinoma: Association Between Germline DNA Variant Markers and Clinical Parameters-Reference-Cited by-同舟云学术

Papillary Thyroid Carcinoma: Association Between Germline DNA Variant Markers and Clinical Parameters

Published:2016-09 Issue:9 Volume:26 Page:1276-1284
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Jendrzejewski Jaroslaw¹²,Liyanarachchi Sandya¹,Nagy Rebecca¹,Senter Leigha¹,Wakely Paul E.³,Thomas Andrew¹,Nabhan Fadi⁴,He Huiling¹,Li Wei¹,Sworczak Krzysztof²,Ringel Matthew D.⁴,Kirschner Lawrence S.⁴,de la Chapelle Albert¹

Affiliation:

1. Human Cancer Genetics Program, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.

2. Department of Endocrinology and Internal Medicine, Medical University of Gdansk, Gdansk, Poland.

3. Department of Pathology, The Ohio State University, Columbus, Ohio.

4. Division of Endocrinology, Diabetes and Metabolism, The Ohio State University, Columbus, Ohio.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2015.0665

Reference43 articles.

1. Systematic Population-Based Assessment of Cancer Risk in First-Degree Relatives of Cancer Probands

2. Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families

3. Genetic Predisposition to Familial Nonmedullary Thyroid Cancer: An Update of Molecular Findings and State-of-the-Art Studies

4. A germline mutation in SRRM2, a splicing factor gene, is implicated in papillary thyroid carcinoma predisposition

5. Discovery of common variants associated with low TSH levels and thyroid cancer risk

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MBIP promotes ESCC metastasis by activating MAPK pathway;Cellular Signalling;2024-03

2. MBIP promotes ESCC metastasis by activating MAPK pathway;2023-09-26

3. The lncRNA RMST is drastically downregulated in anaplastic thyroid carcinomas where exerts a tumor suppressor activity impairing epithelial-mesenchymal transition and stemness;Cell Death Discovery;2023-07-01

4. Variants in TPO rs2048722, PTCSC2 rs925489 and SEMA4G rs4919510 affect thyroid carcinoma susceptibility risk;BMC Medical Genomics;2023-02-04

5. Genetic Susceptibility to Differentiated Thyroid Cancer;Thyroid Cancer - The Road From Genes to Successful Treatment [Working Title];2022-12-07